Ultra-Low Contrast Angiography in AKI
ConditionAcute Kidney Injury
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-100
SponsorTulane University
About this trial
The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
Eligibility criteria
Qualifiers
Hospitalized patients who have AKI at admission or who develop AKI during admission and require invasive coronary angiography will be included in the trial.
Disqualifiers
Stabilized renal function manifested by unchanged or downtrending serum creatinine during a 24-hour period prior to enrollment.
Contraindication for invasive coronary angiography other than AKI.
Percutaneous coronary intervention is indicated and cannot be postponed by 7 days.
Need for renal replacement therapy before coronary angiography or planned renal replacement therapy after coronary angiography (if premeditated before coronary angiography).
Trial design
Treatments tested in this trial
- Angiography
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov